Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Manon Weis"'
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
In the last years, immunotherapies have shown tremendous success as treatments for multiple types of cancer. However, there are still many obstacles to overcome in order to increase response rates and identify effective therapies for every individual
Externí odkaz:
https://doaj.org/article/db86b38fb77b4bd18a74fff865bdc14d
Autor:
Patrik Kehler, Theresa Neumann, Anika Jaekel, Manon Weis, Johanna Gellert, Antje Danielczyk, Evelyn Hartung, Timo Lischke, Stephanie Gurka, Naomi Kast, Manon Weiske
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00fc472e81e39f9c863f2968284069b1
https://doi.org/10.1136/jitc-2022-sitc2022.1346
https://doi.org/10.1136/jitc-2022-sitc2022.1346
Autor:
Patrik Kehler, Anika Jaekel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Evelyn Hartung, Lisa Weiß, Manon Weis, Stephanie Gurka, Sophie Marinoff, Naomi Kast, Manon Weiske, Marianne Morche, Johanna Gellert, Theresa Neumann
Publikováno v:
Cancer Research. 82:316-316
Background: Highly potent therapeutic approaches require very clean targets. However, the majority of antibodies in clinical development or approved for cancer therapy address protein targets that are only overexpressed on cancer cells and yet often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::153c4b21ea1f186d7b72b8327ed12c6d
https://doi.org/10.1158/1538-7445.am2022-316
https://doi.org/10.1158/1538-7445.am2022-316
Autor:
Theresa Neumann, Evelyn Hartung, Johanna Gellert, Lisa Weiß, Manon Weiske, Naomi Kast, Stephanie Gurka, Sophie Marinoff, Anika Jäkel, Antje Danielczyk, Patrik Kehler
Publikováno v:
Frontiers in Drug Discovery, Vol 3 (2023)
Introduction: One of the most drastic changes in cancer is the altered glycosylation of proteins and lipids, giving rise to truncated O-glycans like the Thomsen Friedenreich (TF) or Thomsen nouvelle (Tn) antigen, which are almost absent on normal cel
Externí odkaz:
https://doaj.org/article/1642fa48651b41748ba0b68dfa45fd4f
Publikováno v:
Cancer Research. 77:4977-4977
Some of the challenges regarding adoptive T cell transfer as an immunotherapeutic approach for the treatment of cancer patients include the initial induction, isolation and later characterization of suitable TCR candidates. In addition, the selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::faad694258c6715ca9d674cbb2e99403
https://doi.org/10.1158/1538-7445.am2017-4977
https://doi.org/10.1158/1538-7445.am2017-4977
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dolores J. Schendel, Silke Raffegerst, Judith Eckl, Nadja Sailer, Manon Weis, Barbara Mosetter, Christian Ellinger, Slavoljub Milosevic, Susanne Wilde, Bernhard Frankenberger, Giulia Longinotti, Carina Wehner
Publikováno v:
Journal for Immunotherapy of Cancer
In recent years, activation of the patient's immune system to defend against tumors was demonstrated to be a promising alternative strategy to classical cancer treatments. Dendritic cells (DCs) can present antigens on MHC-II and -I leading to the act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a307b62eb3d2c7472e3a6f7f854ede47